Objective: To evaluate relationships between HIV-1 evolution, including immune evasion, and markers of disease progression during chronic infection.
Introduction
HIV-1 is notable for its vast ability to evolve as a result of its error-prone reverse transcriptase and high rate of virus production. Within-host HIV-1 evolution is characterized by diversification of the infecting virus population throughout the course of infection [1] . In addition to genetic drift and purifying selection, HIV-1 can evolve under positive selection from antibodies and cytotoxic T lymphocytes (CTLs) [1] . However, it remains unclear to what extent virus evolution and escape from immune pressure contribute to HIV-1 disease progression.
Studies examining whether the extent of HIV-1 evolution is associated with disease progression have had conflicting results. HIV-1 evolution is most commonly evaluated by measuring viral diversity and divergence in nucleotide sequences as well as indicators of selection such as the ratio of nonsynonymous to synonymous change (dN/dS). Shankarappa et al. [2] described a consistent pattern of increasing virus diversity and divergence throughout infection, which was temporally associated with progression to AIDS. In concordance with this, Markham et al. [3] found greater HIV-1 diversity and divergence, as well as evidence of adaptive evolution, in rapid progressors compared with moderate or slow progressors. By contrast, Ganeshan et al. [4] found greater diversity and stronger evidence of adaptive evolution in slow progressors than in rapid progressors. The conflicting results of these and other studies, which included a relatively small number of participants (15) [5] [6] [7] [8] , highlight the need for larger studies to assess the relationship between HIV-1 evolution and disease progression.
The relationship between HIV-1 evolution and disease progression remains particularly unclear with respect to an important component of HIV-1 evolution, evasion of the adaptive immune response. For example, some individual CTL escape mutations are associated with disease progression [9] [10] [11] [12] , whereas others are not because they impose a fitness cost on the virus [13] [14] [15] [16] [17] . Similarly, there is strong evidence that HIV-1 evolves to escape from neutralizing antibodies (NAbs) throughout infection [18, 19] , but it is not clear whether this leads to disease progression. One study found an inverse relationship between viral load and the level of autologous neutralization in cross-sectional analysis [20] , suggesting that NAb escape facilitates disease progression. However, other studies have demonstrated that longitudinal escape from NAb is not a correlate of disease progression [21, 22] .
Many previous studies of HIV-1 evolution, disease progression, and the immune response have been limited by cross-sectional study designs, small numbers of participants, or small numbers of sequences studied per participant. In addition, prior studies have generally focused on one HIV-1 gene and one immune parameter. Here, we present analyses of HIV-1 evolution among 37 Kenyan women followed for an average of 5 years after infection. The primary goal of this study was to evaluate the relationship between HIV-1 evolution and disease progression and to compare this relationship in two different genes, gag and env. Because these genes are primary targets of different arms of the immune response (CTLs and NAb, respectively), immune evasion was also evaluated in relation to virus evolution. This is the first study to directly compare the potential role of both immune factors in driving HIV-1 evolution and disease progression.
Methods
Study population Individuals in this study were part of a prospective seroincident cohort of high-risk Kenyan women [23] . Methods for determining the timing of HIV-1 infection and measuring plasma viral load and CD4 cell count have been described previously [24] . Viral load set point was defined as the first available measurement 4-24 months after infection [24] . Thirty-seven women were included in this study, which was restricted to those who had a blood sample taken within the first year of infection, were antiretroviral naive at the time of sample collection, and were not coinfected or superinfected [25, 26] . In addition, all women in this study had subtype A viruses based on env V1-V3 sequences [27] ; however, gag sequencing ultimately revealed that six women were initially infected with recombinant viruses containing subtype D in gag (described in results). The study was approved by the ethical review committees of the University of Nairobi, the University of Washington, and the Fred Hutchinson Cancer Research Center.
Sequence analysis HIV-1 sequences were obtained as described previously [26, 28] . Briefly, proviral DNA was extracted from frozen peripheral blood mononuclear cells (PBMCs) using the QIAamp DNA Blood Mini kit (Qiagen, Valencia, California, USA), and the HIV-1 proviral copy number was estimated using quantitative PCR [29, 30] . Envelope V1-V5 (1.2 kb) and gag p17-partial p24 (700 bp) were amplified in separate nested PCRs, each from an estimated single copy of proviral template, using previously published primers [26] . PCR products were sequenced directly. A median of eight gag sequences (range, [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] and seven env sequences (range, [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] were obtained from each sample. Gag and env V1-V3 sequences from seven of the 37 individuals were published previously [28] .
Sequences were assembled using Sequencher (Gene Codes, Ann Arbor, Michigan, USA) and aligned using MacClade 4.0 [31] . Regions that could not be unambiguously aligned between different individuals (mainly regions of env V1/V2 and V4) were removed from the analysis. Although this likely led to an underestimation of the env diversity within each individual, it allowed us to compare the same region of the gene across all individuals. For each individual, the most recent common ancestor (MRCA) of the sequences from the early sample was reconstructed using maximum likelihood in GARLI 0.95 [32] . Genetic distances were calculated using a general time reversible model (g ¼ 0.5) in PAUP (Phylogenetic Analysis Using Parsimony) [33] . Synonymous and nonsynonymous substitution rates were determined using SNAP (Synonymous Non-synonymous Analysis Program) (www.hiv.lanl.gov) [34] . Amino acid changes were defined as positions at which two or more of the chronic infection sequences shared an amino acid that was different from the MRCA.
Mutations in gag cytotoxic T-lymphocyte epitopes Each individual's human leukocyte antigen (HLA)-A, B, and C types were determined using an intermediate resolution reverse probe typing system (LabType, One Lambda, Canoga Park, California, USA) in collaboration with the Clinical Immunogenetics Laboratory at the Seattle Cancer Care Alliance. LabType employs locusspecific primers to amplify exons 2 and 3 of the known alleles for the HLA-A, B, and C loci. Amplified sample DNA is hybridized with panels of sequence-specific oligonucleotide probes bound to color-coded microspheres. Probe reactions are captured with a Luminex flow analyzer, and an analysis program compares the pattern of positive and negative probe reactions with a library of known HLA alleles and assigns the typing result.
For each allele, published CTL epitopes were identified using the HIV Molecular Immunology database (www.lanl.gov). For each individual, we calculated both the total number of amino acid changes in CTL epitopes and the percentage of the total epitopes that contained at least one amino acid change ('epitopes changed').
Measurement of neutralizing antibody breadth
Plasma from each individual was tested against a panel comprised of SF162, an easy to neutralize subtype B virus, as well as five subtype-A viruses, Q461d1, Q168b23, Q769h5, Q842d16, and Q259d2.17. These subtype A viruses, which were isolated from other individuals in the Mombasa cohort early in infection [35] , were selected because they represent a range of neutralization sensitivities [36] . The median pair-wise difference between these sequences is 13.7% (range, 10.2-18.8%) across the V2-V5 region, and they are further described in [36] . The TZM-bl neutralization assay used for this study has been described [36, 37] . Each plasma-virus combination was tested in duplicate using plasma dilutions of 1 : 100-1 : 1600, and the 50% maximal inhibitory concentration (IC 50 ) was calculated from the mean of the duplicate results as the reciprocal plasma dilution required for 50% inhibition. The median IC 50 for each virus against all plasma samples was determined, and the NAb breadth score for each plasma was calculated as the number of panel viruses that were neutralized to greater than the median for that experiment. The breadth scores reported are the mean of three independent experiments.
Statistical analyses
Associations between diversity, divergence, plasma viral load, CD4 cell count, and immune parameters were assessed using the nonparametric Spearman's rank correlation test for univariate comparisons and linear regression for multivariate analyses. The Wilcoxon signed-rank test was used to compare various measurements of evolution between genes. All analyses were performed in STATA 9 (Stata, College Station, Texas, USA) [38] .
Results
Characterization of HIV-1 evolution in gag and env To measure HIV-1 evolution within infected individuals, we examined a total of 651 gag and 542 env sequences in a longitudinal study of 37 Kenyan women. Proviral sequences were sampled at two times in infection: an 'early time point,' which was a median of 88 days after infection (range, 16-299), and a 'chronic infection time point,' which was a median of 5.3 years after infection (range, 2.0-7.2). Phylogenetic analysis and genotyping indicated that all env sequences belonged to subtype A, which was a selection criterion for this study, whereas in gag, we detected subtype A (31 individuals), subtype D (two individuals), and A/D recombinant (four individuals).
For each individual, we calculated the HIV-1 sequence diversity as the mean pair-wise distance between sequences at a given time point. As shown in Fig. 1 , the diversity in each gene was lower in early infection than in chronic HIV-1 evolution and disease progression Piantadosi et al. infection, and gag diversity was lower than env diversity at both time points. The median HIV-1 diversity among all individuals at the early time point was 0.2% in gag and 0.3% in env. At the chronic infection time point, the median HIV-1 diversity was 1.1% in gag and 2.7% in env. To measure the extent of evolution from early to chronic infection, we reconstructed the MRCA of each individual's early sequences and calculated divergence as the mean distance from a chronic infection sequence to the MRCA. As with diversity, divergence was lower for gag (median, 1.7%) than for env (median, 3.1%) (Fig. 1) . Thus, the average divergence was 0.3% per year in gag and 0.6% per year in env. It should be noted that the env diversity and divergence reported here are likely an underestimate of these values across all of V1-V5 because certain highly variable regions were excluded from analysis in order to compare the same region across all individuals.
We found strong correlations between HIV-1 evolution in these two genes as well as across these two times in infection. As shown in Fig. 1 , there was a high correlation between gag diversity and env diversity at both time points as well as between gag divergence and env divergence. Furthermore, within each gene, there was a high correlation between measures of evolution in early and chronic infection. Thus, individuals who had a high diversity in early infection continued to have a high diversity in chronic infection as well as high divergence (P 0.01 for all comparisons).
To measure selection in these genes, we compared synonymous (dS) and nonsynonymous (dN) divergence from the MRCA as well as the dN/dS ratio. As shown in Table 1 , we observed comparable levels of synonymous divergence in gag and env; however, nonsynonymous divergence was significantly lower in gag than in env. Consequently, the dN/dS ratio was significantly lower in gag than in env (median dN/dS, 0.4 for gag and 1.5 for env; P < 0.001). As indicated in Table 1 , the dN/dS ratio in gag was less than or equal to one in all individuals, indicating overall purifying selection. By contrast, the env dN/dS ratio was higher than one for 75% of these individuals, and the average env dN/dS ratio among all individuals was statistically significantly higher than one (t-test, P < 0.001), indicating overall positive selection in this gene. In addition to comparing evolution at the nucleotide level, we also examined amino acid changes and found a significantly higher percentage of amino acids changed in env than in gag (Table 1) . Together, these results demonstrate that, although evolution between these genes is highly correlated, there is increased evolution and positive selection in env than in gag.
Associations between virus evolution and viral load To evaluate whether evolution in gag or in env or in both was associated with measures of disease progression during chronic infection, plasma viral load was examined at the chronic infection time point and CD4 cell count at or within 6 months of the chronic infection time point. The median plasma viral load was 5.1 log 10 copies/ml (range, 2.6-6.9, available for 33 women), and the median CD4 cell count was 382 cells/ml (range 37-1088, available for 28 women). Greater divergence in gag, but not in env, was associated with a higher viral load at the chronic infection time point [r ¼ 0.45, P ¼ 0.009 for gag (Fig. 2a) ; r ¼ 0.25, P ¼ 0.2 for env (Fig. 2b) ]. Divergence in gag but not in env was highly inversely correlated with CD4 cell count in chronic infection ( Fig. 2c and d) . Because viral load during chronic infection could be affected by time since infection and viral load set point, we performed multivariate linear regression analysis adjusting for these factors. We found that gag divergence remained significantly associated with viral load at the chronic infection time point. Each 1% increase in gag divergence was associated with a 0.69 log 10 copies/ml higher viral load (P ¼ 0.01).
An association between HIV-1 evolution and viral load could reflect either selection for viruses of high fitness or the accumulation of random changes through many rounds of virus replication. Therefore, we independently examined synonymous and nonsynonymous divergence in gag. Viral load was highly correlated with gag dS (r ¼ 0.56, P < 0.001) but was only marginally, and not statistically significantly, associated with gag dN (r ¼ 0.32, P ¼ 0.07). Thus, synonymous changes are likely to contribute significantly to the association that we observed between gag divergence and viral load, although we could not exclude a small contribution by nonsynonymous changes.
Mutations in cytotoxic T-lymphocyte epitopes
To further evaluate whether the nonsynonymous divergence observed in gag might reflect functional changes that could contribute to higher viral load, we evaluated amino acid changes that occurred in published CTL epitopes (www.hiv.lanl.gov). For this purpose, each individual's HLA-A, B, and C alleles were determined to intermediate resolution. We observed a total of 12 different HLA-A alleles, 17 different HLA-B alleles, and 10 different HLA-C alleles. The alleles that we detected at high frequency (15% or higher) were A02, A30, C06, and C07, which have also been reported at high frequency in other African cohorts [39] [40] [41] .
For each HLA allele, published CTL epitopes were identified using the LANL HIV Immunology database. There were no published HIV-1 CTL epitopes for 13 alleles that we detected, although only one of these (C07) was present at high frequency in our cohort. For each individual, we calculated the total number of amino acid changes that occurred in published gag CTL epitopes. Individuals had a median of two amino acid changes in published gag CTL epitopes (range, 0-5), representing 30% (0-100) of the total number of amino acid changes in gag. However, there was no association between the number of amino acid changes in gag CTL epitopes and viral load (Fig. 3a) .
For each individual, we also calculated the percentage of gag epitopes that contained at least one change ('epitopes changed'). Individuals had a median of 27% of epitopes changed (range, 0-100). Individuals with a higher percentage of epitopes changed had higher viral loads during chronic infection (r ¼ 0.44, P ¼ 0.01) (Fig. 3b) . This association remained significant in multivariate linear regression analysis controlling for time since infection and viral load set point. For every additional 10% of epitopes changed, viral load was 0.15 log 10 copies/ ml higher (P ¼ 0.04). Therefore, mutations in gag CTL epitopes represent another factor contributing to the observed relationship between gag evolution and viral load during chronic infection.
Neutralizing antibody breadth
Whereas gag evolution was most likely to have been driven by CTL pressure, we hypothesized that evolution in env may have been modulated by the NAb response. To address this, the breadth of the NAb response in each individual was measured at or within 1 year of the chronic infection time point (median, 4.9 years after infection; range, 2.0-6.8). The NAb breadth of each plasma sample was calculated as the number of panel viruses (out of six) that were neutralized to greater than the median for that virus, to control for differences in neutralization susceptibility between viruses (Fig. 4) . The median NAb breadth score (out of a possible 6) was 2 (range, 0-5.3). NAb breadth was not associated with viral load during chronic infection (r ¼ 0.29, P ¼ 0.12). NAb breadth was also not associated with env diversity or divergence during chronic infection (P > 0.2 for both). There was a trend for an association between NAb breadth and percentage amino acid change in envelope (r ¼ 0.31, P ¼ 0.07). Together, these data suggest that NAb breadth, as measured by neutralization of heterologous viruses, is not a dominant selective force on env evolution or virus replication as measured by viral load.
Discussion
We evaluated the relationship between HIV-1 evolution and disease progression in a longitudinal study of 37 Kenyan women. The strengths of this study include the relatively large study population and the examination of many sequences from two genes, which are targets of different adaptive immune responses, at two times in infection. Evolution was highly correlated between gag and env as well as between early and chronic infection, suggesting that the diversity of the initial virus population influences subsequent evolution. Although there were This table lists the  IC 50 , the reciprocal dilution of plasma that neutralizes 50% of virus, for each plasma sample (rows) screened against each of six panel viruses (columns). The highest plasma dilution tested was 1 : 100, and samples that were not neutralized at this dilution were given the reciprocal IC 50 value of 50. IC 50 values that are higher than the assay median for each virus are highlighted in gray. For each plasma sample, the neutralizing antibody breadth score was calculated as the number of panel viruses (out of six) neutralized at a IC 50 higher than the assay median. This assay was repeated in triplicate for each plasma sample from 36 out of 37 individuals, and the average of three scores was used in later analyses. IC 50 , 50% maximal inhibitory concentration; NAb, neutralizing antibody.
strong associations between gag and env evolution, env had greater diversity at both time points and greater divergence from early to chronic infection.
Further examination of evolution in these genes revealed that there was no significant difference in synonymous divergence between gag and env. This suggests that the correlation between evolution in these genes may be largely due to the accumulation of random changes. This interpretation is supported by the association between synonymous divergence in gag and viral load; viruses that replicate more will generate both higher viral loads and more synonymous changes. It is interesting that we did not find a relationship between synonymous evolution in env and viral load as in a study by Lemey et al. [42] . A possible explanation is that several individuals in our study had high early env diversity (up to 6.4%), which is not unusual for women who acquire HIV-1 through heterosexual transmission [43, 44] . High early diversity could disrupt the relationship between synonymous divergence and viral load because it introduces evolution that occurred in the transmitting partner. Importantly, all of the early sequences from each individual were monophyletic, indicating that there was no evidence for coinfection with two different HIV-1 strains in any individual [26] . Two individuals had notably high early diversity in env (>2%); however, removing them from analyses did not significantly alter the results (not shown).
In addition to finding greater diversity and divergence in env than in gag, we also found evidence for overall positive selection in env and purifying selection in gag. Because NAbs represent a potential selective force acting on env but not on gag, we evaluated the breadth of the NAb response in these individuals against a panel of unrelated viruses. There was substantial variation in heterologous NAb breadth, ranging from no detectable neutralization to neutralization of five out of six panel viruses at high levels. Although the TZM-bl neutralization assay may have limitations as compared with the 'gold standard' PBMC assay [45, 46] , this highly reproducible approach allowed us to compare NAb breadth across individuals in a standardized assay. Individuals who mounted a broader NAb response had more amino acid changes in env, although this did not achieve statistical significance (P ¼ 0.07). This result is consistent with a prior study in which env amino acid changes were associated with escape from autologous NAb [22] . In this study, we did not assess autologous NAb, which would provide more direct information about the selective pressure faced by these viruses in vivo. Nevertheless, our results are consistent with a model proposed by Frost et al. [22] , in which NAbs exert 'soft' selective pressure that favors the growth of some virus variants over others but does not limit overall growth of the virus population. In concordance with this, we did not observe an association between virus replication, as measured by viral load, and either NAb breadth or env diversity or divergence.
In contrast to NAbs, CTLs have been proposed to exert 'hard' selective pressure that limits the overall virus population size [22] ; therefore, escape from CTLs should allow increased virus replication. Supporting this model, we found that individuals with a higher percentage change of gag CTL epitopes had higher viral loads in chronic infection. A similar relationship between viral load and percentage change of CTL epitopes was observed in a large cross-sectional study [47] . Confirmation of this association by our longitudinal study strengthens the idea that CTL escape may generally contribute to disease progression. A limitation of our study is that we did not perform in-vitro experiments to confirm CTL recognition or escape. However, previous studies have demonstrated associations between mutations in CTL epitopes and in-vitro escape [47] [48] [49] .
Another limitation of this study is that our estimates of HIV-1 evolution are based on proviral HIV-1 sequences, some of which may be defective. However, other studies have shown that overall patterns of HIV-1 evolution between DNA and RNA are similar [2, 50] , suggesting that our estimates may be relevant to both sequence types. Importantly, another study demonstrated that the predominant variants found in proviral sequences were maintained after culture, indicating that they are replication-competent [51] .
Our study is the first to directly compare longitudinal relationships between HIV-1 evolution in two genes, immune evasion, and disease progression. Our results support a model in which HIV-1 gag and env evolve in a concerted manner, largely because of similar rates of synonymous evolution. However, because these genes are the primary targets of different adaptive immune responses, gene-specific evolution also occurs. Adaptive evolution in gag is relatively rare but may promote disease progression via CTL escape, whereas adaptive evolution in env is common and may reflect escape from NAb but does not significantly affect viral load. Further longitudinal studies are needed to more clearly elucidate the selective forces acting on env, including autologous NAb. Ultimately, a better understanding of how HIV-1 evolves in response to immune pressure, and how this contributes to disease progression, will provide insight into achieving immune-mediated control of HIV-1 infection.
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